Cell type-specific targeting with Sindbis pseudotyped lentiviral vectors displaying anti-CCR5 single-chain antibodies

被引:20
作者
Da Silva, FA
Costa, MJL
Corte-Real, S
Goncalves, J
机构
[1] URIA, Ctr Patogenese Mol, Fac Farm Lisboa, P-1649019 Lisbon, Portugal
[2] Univ Tecn Lisboa, Ctr Engn Biol & Quim, Inst Super Tecn, P-1049001 Lisbon, Portugal
关键词
D O I
10.1089/hum.2005.16.223
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 [微生物学]; 0836 [生物工程]; 090102 [作物遗传育种]; 100705 [微生物与生化药学];
摘要
Lentiviral vectors are among the most efficient tools for gene delivery into mammalian cells. A major goal of lentiviral gene delivery systems is to develop vectors that can efficiently target specific cell types. In the present work, we attempt to generate viral particles for targeting gene delivery. We have used CCR5-positive cells as the target for our strategy. Therefore, we developed a novel Sindbis pseudotyped lentiviral vector where the Sindbis receptor binding envelope protein was modified to directly encode a single-chain antibody fragment ( scFv) against the CCR5 chemokine receptor. We have generated two chimeric scFv-Sindbis envelopes, varying the length of the peptide linker that connects the heavy chain and light chain of anti-CCR5 scFv. The two chimeric scFv-Sindbis envelopes were successfully incorporated into lentiviral-derived vectors, and the resulting pseudotyped viral particles showed specific targeting to CCR5-expressing cells. However, our data demonstrate that the length of the peptide linker significantly affects the efficiency of infection. Pseudotyped viral particles, which display single-chain antibody fragments with longer peptide linkers, allowed higher titers of infection. The present study can be a model strategy for specific gene delivery mediated by lentiviral vectors pseudotyped with Sindbis envelope displaying scFv that recognizes specific cellular surface proteins. Furthermore, this strategy has the potential to become a powerful approach for targeting gene delivery in anti-HIV gene therapy due to the important role of CCR5 expression in disease progression.
引用
收藏
页码:223 / 234
页数:12
相关论文
共 42 条
[1]
Akkina R, 2003, ANTICANCER RES, V23, P1997
[2]
Barbas C. F., 2001, PHAGE DISPLAY LAB MA
[3]
Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease [J].
Berger, EA ;
Murphy, PM ;
Farber, JM .
ANNUAL REVIEW OF IMMUNOLOGY, 1999, 17 :657-700
[4]
Bjorndal A, 1997, J VIROL, V71, P7478
[5]
Retroviral vectors preloaded with a viral receptor-ligand bridge protein are targeted to specific cell types [J].
Boerger, AL ;
Snitkovsky, S ;
Young, JAT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (17) :9867-9872
[6]
Toward highly efficient cell-type-specific gene transfer with retroviral vectors displaying single-chain antibodies [J].
Chu, THT ;
Dornburg, R .
JOURNAL OF VIROLOGY, 1997, 71 (01) :720-725
[7]
Change in coreceptor use correlates with disease progression in HIV-1-infected individuals [J].
Connor, RI ;
Sheridan, KE ;
Ceradini, D ;
Choe, S ;
Landau, NR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (04) :621-628
[8]
Camelized rabbit-derived VH single-domain Intrabodies Against vif strongly neutralize HIV-1 infectivity [J].
da Silva, FA ;
Santa-Marta, M ;
Freitas-Vieira, A ;
Mascarenhas, P ;
Barahona, I ;
Moniz-Pereira, J ;
Gabuzda, D ;
Goncalves, J .
JOURNAL OF MOLECULAR BIOLOGY, 2004, 340 (03) :525-542
[9]
Identification of a major co-receptor for primary isolates of HIV-1 [J].
Deng, HK ;
Liu, R ;
Ellmeier, W ;
Choe, S ;
Unutmaz, D ;
Burkhart, M ;
DiMarzio, P ;
Marmon, S ;
Sutton, RE ;
Hill, CM ;
Davis, CB ;
Peiper, SC ;
Schall, TJ ;
Littman, DR ;
Landau, NR .
NATURE, 1996, 381 (6584) :661-666
[10]
GENE-THERAPY FOR HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION - GENETIC ANTIVIRAL STRATEGIES AND TARGETS FOR INTERVENTION [J].
DROPULIC, B ;
JEANG, KT .
HUMAN GENE THERAPY, 1994, 5 (08) :927-939